在儿童患者中药物不良反应的复发分析
Ernestina Hernández García1, Brenda Lambert Lamazares2, Gisela Gómez-Lira3
1Laboratorio de Farmacología, Subdirección de Medicina Experimental, Instituto Nacional de Pediatría, Ciudad de México 04530, Mexico.
Pharmaceuticals (Basel, Switzerland)
|August 28, 2025
概括
这项研究对住院儿科患者的抗发作药物反复出现的不良反应 (ADR) 进行了研究. 年龄较小和焦点发作增加了副作用的风险,而某些ASM则显示了不严重和严重事件的风险概况.
科学领域:
- 神经学
- 药理学
- 儿童医学
背景情况:
- 是一种常见的儿童慢性神经疾病.
- 抗发作药物 (ASM) 可能导致复发性不良反应 (ADR).
- 了解副作用的复发对于有效的儿科治疗至关重要.
研究的目的:
- 在住院的墨西哥儿科患者中分析ASM引起的副作用的复发情况.
- 确定与ASM引起的副作用复发相关的危险因素.
- 为了比较不同ASM的副作用的复发风险.
主要方法:
- 在122个月内对313名住院儿科患者进行了回顾性分析.
- 使用四种统计模型来分析反复发生的事件 (定义为一天内发生的一种或多种不良反应).
- 考虑患者的人口统计,发作类型,营养状况和同时服用的药物作为解释变量.
主要成果:
- 确定了499例复发事件;年轻患者和焦点发作患者的非严重副作用风险更高.
- 营养不良与较低的非严重副作用风险相关,而肥胖与较高的严重副作用风险相关.
- 与酸 (VPA) 相比,酸 (LEV) 增加了非严重的副作用风险,但降低了严重的副作用风险;酸 (PHT) 与VPA相比增加了风险.
结论:
- 年龄较小,焦点发作和营养状况是儿童中ASM-ADR复发的重要预测因素.
- 不同的ASM (LEV,PHT,VPA) 呈现出不同的不严重和严重的副作用风险概况.
- 这项研究为儿童患者预测和管理ASM-ADR风险提供了临床工具.
相关概念视频
Pharmacovigilance
983
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
983
Epilepsy and Seizures: Overview
275
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
275
Antiepileptic Drugs: Potassium Channel Activators
274
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
274
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
445
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
445
Desensitization and Tachyphylaxis
2.2K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.2K
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K


